Quotient Ltd (QTNT)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

28 ESPLANADE SAINT HELIER, JERSEY JE2 3QA

Quotient Ltd develops and manufactures transfusion diagnostic products. The company provides tests for blood grouping and serological disease screening, commonly referred to as transfusion diagnostics.

Data based on most recent fiscal year report
Market Cap682.928 Million Shares Outstanding80.25 Million Avg Volume454.409 Thousand
1-Yr BETA vs S&P TR1.137 Current Ratio4.59 Quick Ratio3.98
View SEC Filings from QTNT instead.

View recent insider trading info

Funds Holding QTNT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding QTNT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

40 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

73.6 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WALT FRANZ CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
315,520 2020-03-24 17

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
16,584,802 2020-03-19 1

VON PRONDZYNSKI HEINO

  • Director
239,922 2020-03-13 6

BUHLER PETER CHIEF FINANCIAL OFFICER

  • Officer
10,000 2020-03-13 3

LINDOP CHRISTOPHER J EVP

  • Officer
351,376 2020-02-09 2

WILKERSON L JOHN

  • Director
  • 10% Owner
7,362,645 2020-01-31 4

HALLSWORTH FREDERICK

  • Director
93,643 2020-01-31 5

BOLOGNA THOMAS A

  • Director
177,334 2020-01-31 4

SHROFF ZUBEEN

  • Director
  • 10% Owner
7,362,645 2020-01-31 4

MCDONOUGH BRIAN

  • Director
89,193 2020-01-31 4

OCONNOR SARAH A

  • Director
50,351 2020-01-31 4

FARRELL EDWARD CHIEF OPERATING OFFICER

  • Officer
14,566 2020-01-07 5

LARNACH ERNEST SEE REMARKS

  • Officer
4,333 2020-01-01 1

BOYD ROLAND SEE REMARKS

  • Officer
70,508 2019-08-19 2

STACKAWITZ JEREMY PRESIDENT

  • Officer
131,939 2019-05-29 4

GALEN PARTNERS V LP

GALEN PARTNERS INTERNATIONAL V LP

GALEN MANAGEMENT, LLC

GALEN PARTNERS V, L.L.C.

  • Director
  • 10% Owner
7,329,074 2018-07-23 0

COWAN D J PAUL E SEE REMARKS

  • Officer
  • Director
3,216,654 2017-10-30 0

COWAN DEIDRE

QUOTIENT BIODIAGNOSTICS GROUP LTD

  • 10% Owner
3,585,175 2016-08-03 0

UNGER STEPHEN CHIEF FINANCIAL OFFICER

  • Officer
0 2016-06-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WALT FRANZ - Director - Officer CHIEF EXECUTIVE OFFICER

2020-03-24 M 7,645 a 315,520 315,520.00 direct

WALT FRANZ - Director - Officer CHIEF EXECUTIVE OFFICER

2020-03-24 M 7,645 d 15,291 315,520.00 direct

VON PRONDZYNSKI HEINO - Director

2020-03-13 P 30,000 $4.00 a 239,922 239,922.00 direct

BUHLER PETER - Officer CHIEF FINANCIAL OFFICER

2020-03-13 P 10,000 $4.04 a 10,000 10,000.00 direct

WALT FRANZ - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-24 M 7,645 d 22,936 307,875.00 direct

WALT FRANZ - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-24 M 7,645 a 307,875 307,875.00 direct

LINDOP CHRISTOPHER J - Officer EVP

2020-02-09 M 58,334 a 351,376 351,376.00 direct

LINDOP CHRISTOPHER J - Officer EVP

2020-02-09 M 58,334 d 0 351,376.00 direct

BUHLER PETER - Officer CHIEF FINANCIAL OFFICER

2020-02-05 A 50,000 a 50,000 0.00 direct

BUHLER PETER - Officer CHIEF FINANCIAL OFFICER

2020-02-05 A 25,000 a 25,000 0.00 direct

Elevate your investments